Cimiracemoside C

CAS No. 256925-92-5

Cimiracemoside C ( Cimicifugoside M )

Catalog No. M24157 CAS No. 256925-92-5

Cimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 149 In Stock
10MG 255 In Stock
25MG 430 In Stock
50MG 618 In Stock
100MG 861 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cimiracemoside C
  • Note
    Research use only, not for human use.
  • Brief Description
    Cimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
  • Description
    Cimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
  • Synonyms
    Cimicifugoside M
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    256925-92-5
  • Formula Weight
    620.8
  • Molecular Formula
    C35H56O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C[C@]12[C@@]3([H])[C@@]4(CC[C@@]1([C@]5([H])C(O[C@H](C(C)(O)C)[C@@]6([H])C[C@H]5C)(O6)[C@@H]2O)C)[C@@]7([C@@](C(C)([C@@H](O[C@@]8([H])[C@@H]([C@H]([C@@H](O)CO8)O)O)CC7)C)([H])CC3)C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice.Phytomedicine. 2014 Sep 25;21(11):1382-9.
molnova catalog
related products
  • 7-Methoxyisoflavone

    7-Methoxyisoflavone is an activator of adenosine monophosphate-activated protein kinase (AMPK).

  • A-769662

    A small molecule AMPK activator that directly stimulates partially purified rat liver AMPK (EC50=0.8 uM) and inhibits fatty acid synthesis in primary rat hepatocytes (IC50=3.2 uM).

  • GSK621

    GSK621 (GSK-621) is a potent, specific AMPK agonist (activator), induces cytotoxicity in AML (IC50=13-30 uM).